πŸ‡ΊπŸ‡Έ FDA
Patent

US 10577347

Crystalline forms of a biphenyl compound

granted A61KA61K31/13A61K31/4545

Quick answer

US patent 10577347 (Crystalline forms of a biphenyl compound) held by Theravance Biopharma R&D IP, LLC expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/13, A61K31/4545, A61K31/56, A61K31/58